Royal Bank of Canada
RNVA

Royal Bank of Canada’s Rennova Health, Inc. RNVA Stock Holding History

Royal Bank of Canada’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4
Closed -$3K – 6893
2015
Q4 		$3K Buy
+4
New +$6.92K ﹤0.01% 6318

Other funds holding RNVA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's RNVA Position: Q1 2016 in Review

Royal Bank of Canada sold out of Rennova Health, Inc. (RNVA) in Q1 2016, closing a stake of 4 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in RNVA in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 10 funds tracked by Wall St. Rank hold RNVA as of Q1 2016.

  • Royal Bank of Canada reported no remaining Rennova Health, Inc. position as of Q1 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 4 Rennova Health, Inc. shares in Q1 2016, an estimated $3K.
  • Royal Bank of Canada first reported a position in Rennova Health, Inc. in Q4 2015 and held it in 1 quarter.
  • Royal Bank of Canada's Rennova Health, Inc. position peaked at $3K in Q4 2015.
  • 10 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.